Hélène De Pauw, MPH, is a scientist in the Cancer Epidemiology Unit of the Belgian Cancer Centre at Sciensano, and a PhD candidate at the University of Antwerp. She trained as a nurse (University College of Namur-Liège-Luxembourg) and holds a Master's degree in Sciences of Public Health (Université Catholique de Louvain). She joined Sciensano in 2017. Her research addresses cervical cancer screening and HPV vaccination, with a particular focus on self-sampling as a strategy for reaching under-screened women, notably through the CapU4 trial (NCT05243888). She contributed to the European PERCH project (https://www.projectperch.eu), which aimed to eliminate HPV-related cancers by increasing vaccination. She now leads the working group on sustainability within SHIELD (shield.chip.dk), a European Joint Action to eliminate infection-related cancers. She is a board member of the Community Coordination and Reference Centre for Cancer Screening (CCRef, https://www.ccref.org).